Phase II/III Trials

[1]  Michael A Proschan,et al.  Practical midcourse sample size modification in clinical trials. , 2003, Controlled clinical trials.

[2]  P. Bauer,et al.  Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.

[3]  Michael A. Proschan,et al.  A Unified Theory of Two-Stage Adaptive Designs , 2002 .

[4]  Wolfgang Bischoff,et al.  Adaptive two-stage test procedures to find the best treatment in clinical trials , 2005 .

[5]  Jixian Wang.  An Adaptive Two‐stage Design with Treatment Selection Using the Conditional Error Function Approach , 2006, Biometrical journal. Biometrische Zeitschrift.

[6]  Frank Bretz,et al.  Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts , 2006, Biometrical journal. Biometrische Zeitschrift.

[7]  Peter F Thall,et al.  Seamlessly Expanding a Randomized Phase II Trial to Phase III , 2002, Biometrics.

[8]  Allan R Sampson,et al.  Drop‐the‐Losers Design: Normal Case , 2005, Biometrical journal. Biometrische Zeitschrift.

[9]  P F Thall,et al.  A two-stage design for choosing among several experimental treatments and a control in clinical trials. , 1989, Biometrics.

[10]  Frank Bretz,et al.  Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations , 2006, Biometrical journal. Biometrische Zeitschrift.

[11]  Gordon Pledger,et al.  On design and inference for two-stage adaptive clinical trials with dependent data , 2006 .

[12]  C. Burman,et al.  Are Flexible Designs Sound? , 2006, Biometrics.

[13]  W. Maurer,et al.  Challenges in Implementing Adaptive Designs: Comments on the Viewpoints Expressed by Regulatory Statisticians , 2006, Biometrical journal. Biometrische Zeitschrift.

[14]  P. Canner.  The Coronary Drug Project. Monitoring of the data for evidence of adverse or beneficial treatment effects. , 1983, Controlled clinical trials.

[15]  Terry M. Therneau,et al.  Optimal two-stage screening designs for survival comparisons , 1990 .

[16]  David L. DeMets,et al.  Stopping guidelines vs stopping rules: a practitioner's point of view , 1984 .

[17]  M. Proschan,et al.  Designed extension of studies based on conditional power. , 1995 .

[18]  Qing Liu,et al.  Phase 2 and 3 Combination Designs to Accelerate Drug Development , 2005 .

[19]  Jeff Maca,et al.  Adaptive Seamless Phase II/III Designs—Background, Operational Aspects, and Examples , 2006 .

[20]  Rory A. Fisher,et al.  Theory of Statistical Estimation , 1925, Mathematical Proceedings of the Cambridge Philosophical Society.

[21]  W. Brannath,et al.  Recursive Combination Tests , 2002 .

[22]  Nigel Stallard,et al.  Point estimates and confidence regions for sequential trials involving selection , 2005 .

[23]  Martin Posch,et al.  Testing and estimation in flexible group sequential designs with adaptive treatment selection , 2005, Statistics in medicine.

[24]  D A Follmann,et al.  Monitoring pairwise comparisons in multi-armed clinical trials. , 1994, Biometrics.

[25]  D. DeMets,et al.  Increasing the sample size when the unblinded interim result is promising , 2004, Statistics in medicine.

[26]  Sue-Jane Wang,et al.  Modification of Sample Size in Group Sequential Clinical Trials , 1999, Biometrics.

[27]  David L. DeMets,et al.  Data Monitoring Committees in Clinical Trials , 2002 .

[28]  Nigel Stallard,et al.  An Adaptive Group Sequential Design for Phase II/III Clinical Trials that Select a Single Treatment From Several , 2005, Journal of biopharmaceutical statistics.

[29]  Robert T O'Neill,et al.  A Regulatory View on Adaptive/Flexible Clinical Trial Design , 2006, Biometrical journal. Biometrische Zeitschrift.

[30]  W. Brannath,et al.  An Adaptive Hierarchical Test Procedure for Selecting Safe and Efficient Treatments , 2006, Biometrical journal. Biometrische Zeitschrift.

[31]  Nigel Stallard,et al.  A New Clinical Trial Design Combining Phases 2 and 3: Sequential Designs with Treatment Selection and a Change of Endpoint , 2005 .

[32]  W. Lehmacher,et al.  Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.

[33]  M Kieser,et al.  Combining different phases in the development of medical treatments within a single trial. , 1999, Statistics in medicine.